Canada Markets open in 3 hrs 51 mins

IVERIC bio, Inc. (ISEE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
14.10-0.76 (-5.11%)
At close: 04:00PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.25
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 319.32
52 Week Low 34.96
50-Day Moving Average 316.71
200-Day Moving Average 310.16

Share Statistics

Avg Vol (3 month) 35.11M
Avg Vol (10 day) 31.68M
Shares Outstanding 590.17M
Implied Shares Outstanding 6N/A
Float 873.82M
% Held by Insiders 10.74%
% Held by Institutions 191.53%
Shares Short (Oct. 14, 2021) 412.82M
Short Ratio (Oct. 14, 2021) 45.21
Short % of Float (Oct. 14, 2021) 412.36%
Short % of Shares Outstanding (Oct. 14, 2021) 412.30%
Shares Short (prior month Sep. 14, 2021) 412.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-32.50%
Return on Equity (ttm)-57.11%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-62.78M
EBITDA -107.97M
Net Income Avi to Common (ttm)-107.82M
Diluted EPS (ttm)-1.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)159.88M
Total Cash Per Share (mrq)1.54
Total Debt (mrq)2.04M
Total Debt/Equity (mrq)1.46
Current Ratio (mrq)6.55
Book Value Per Share (mrq)2.13

Cash Flow Statement

Operating Cash Flow (ttm)-85.73M
Levered Free Cash Flow (ttm)-46.51M